Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.2983
-0.0097 (-3.15%)
At close: Jun 13, 2025, 4:00 PM
0.3000
+0.0017 (0.57%)
After-hours: Jun 13, 2025, 7:11 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $18.49 million as of June 13, 2025. Its market cap has decreased by -77.48% in one year.
Market Cap
18.49M
Enterprise Value
2.70M
1-Year Change
-77.48%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $18.49M, a decrease of -92.79%. That is a compound annual growth rate of -51.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 18.49M | -36.53% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |